Evidence Pfizer Could Revisit GlaxoSmithKline Or AstraZeneca Deals If Allergan Falls Through

By: via Benzinga
Despite the proposed merger agreement with Allergan plc Ordinary Shares (NYSE: AGN), analysts have been talking about other potential ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.